These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21285337)

  • 1. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.
    Abramovici G; Mainiero MB
    Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
    Friedlander LC; Roth SO; Gavenonis SC
    Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
    Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
    AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging.
    Marshall AL; Domchek SM; Weinstein SP
    Acad Radiol; 2012 Apr; 19(4):406-11. PubMed ID: 22227041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy.
    Lourenco AP; Chung MT; Mainiero MB
    J Magn Reson Imaging; 2014 Apr; 39(4):789-94. PubMed ID: 24108546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses.
    Berg WA; Cosgrove DO; Doré CJ; Schäfer FK; Svensson WE; Hooley RJ; Ohlinger R; Mendelson EB; Balu-Maestro C; Locatelli M; Tourasse C; Cavanaugh BC; Juhan V; Stavros AT; Tardivon A; Gay J; Henry JP; Cohen-Bacrie C;
    Radiology; 2012 Feb; 262(2):435-49. PubMed ID: 22282182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes of screening breast MRI with practice evolution: initial clinical experience with 3T compared to 1.5T.
    Lourenco AP; Donegan L; Khalil H; Mainiero MB
    J Magn Reson Imaging; 2014 Mar; 39(3):535-9. PubMed ID: 23720144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer yield of probably benign breast MR examinations.
    Eby PR; Demartini WB; Peacock S; Rosen EL; Lauro B; Lehman CD
    J Magn Reson Imaging; 2007 Oct; 26(4):950-5. PubMed ID: 17896380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.
    Baum JK; Hanna LG; Acharyya S; Mahoney MC; Conant EF; Bassett LW; Pisano ED
    Radiology; 2011 Jul; 260(1):61-7. PubMed ID: 21502382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.
    Thomassin-Naggara I; Trop I; Chopier J; David J; Lalonde L; Darai E; Rouzier R; Uzan S
    Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive predictive value of BI-RADS MR imaging.
    Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
    Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.